Get started
Allakos Inc.Allakos Inc.Allakos Inc.

Allakos Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

ALLK chart


Full chart

ALLK upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪120.61 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.03 USD
Net income (FY)
‪−185.70 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪76.54 M‬
Beta (1Y)
−0.20

Employees


Employees (FY)
131
Change (1Y)
+8 +6.50%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.42 M‬ USD

About Allakos Inc.


Sector
Health Technology
CEO
Robert Alexander
Headquarters
San Carlos
Website
allakos.com
Founded
2012
FIGI
BBG003QBJKN0
Allakos, Inc. engages in the development of therapeutic antibodies. Its primary product is AK002, a monoclonal antibody used for the treatment of various eosinophil and mast cell related diseases such as eosinophilic gastritis, urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis. The company was founded by Christopher Bebbington, Nenad Tomasevic, Bruce S. Bochner, and Robert Schleimer in 2012 and is headquartered in San Carlos, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

ALLK news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ALLK is 1.35 USD — it hasn't changed in the past 24 hours. Watch Allakos Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Allakos Inc. stocks are traded under the ticker ALLK.
ALLK stock has risen by 4.65% compared to the previous week, the month change is a 110.94% rise, over the last year Allakos Inc. has showed a −28.57% decrease.
We've gathered analysts' opinions on Allakos Inc. future price: according to them, ALLK price has a max estimate of 7.00 USD and a min estimate of 1.00 USD. Watch ALLK chart and read a more detailed Allakos Inc. stock forecast: see what analysts think of Allakos Inc. and suggest that you do with its stocks.
ALLK reached its all-time high on Feb 10, 2021 with the price of 157.98 USD, and its all-time low was 0.54 USD and was reached on Sep 23, 2024. View more price dynamics on ALLK chart.
See other stocks reaching their highest and lowest prices.
ALLK stock is 5.11% volatile and has beta coefficient of −0.20. Track Allakos Inc. stock price on the chart and check out the list of the most volatile stocks — is Allakos Inc. there?
Today Allakos Inc. has the market capitalization of ‪120.61 M‬, it has increased by 4.20% over the last week.
Yes, you can track Allakos Inc. financials in yearly and quarterly reports right on TradingView.
Allakos Inc. is going to release the next earnings report on Mar 4, 2025. Keep track of upcoming events with our Earnings Calendar.
ALLK earnings for the last quarter are −0.21 USD per share, whereas the estimation was −0.25 USD resulting in a 15.37% surprise. The estimated earnings for the next quarter are −0.21 USD per share. See more details about Allakos Inc. earnings.
Allakos Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
ALLK net income for the last quarter is ‪−18.37 M‬ USD, while the quarter before that showed ‪−26.68 M‬ USD of net income which accounts for 31.13% change. Track more Allakos Inc. financial stats to get the full picture.
No, ALLK doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 131.00 employees. See our rating of the largest employees — is Allakos Inc. on this list?
Like other stocks, ALLK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Allakos Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Allakos Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Allakos Inc. stock shows the sell signal. See more of Allakos Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.